Sort
50,496 grants matching “lung cancer”
Integrated Informatic and Experimental Evaluations of Cancer Chronotherapy
$612,290Ron C. Anafi · University Of Pennsylvania · R01 · FY2023 · CA
Molecular Pathways Regulating Tissue-resident Memory T cells in the Gut
$612,247Michael Lawrence Dougan · Massachusetts General Hospital · R01 · FY2022 · AI
Advanced PET/CT Imaging for Improving Clinical Trials
$612,217Paul E Kinahan · University Of Washington · U01 · FY2019 · CA
Hematopathology Diagnosis
$612,191Elaine Jaffe · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Next Generation Rat Models of ER+ Breast Cancer
$612,175Yi Li · Baylor College Of Medicine · R01 · FY2022 · CA
The Effect of Diet and Nutrients on the Progression and Treatment of Prostate Can
$612,120George Thomas · University Of Cincinnati · U01 · FY2012 · CA
Discovery of the next-generation RET-targeted drugs based on nicotinamide scaffold
$612,099Jie Wu · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2022 · CA
Modeling BRAF-fusion driven pediatric brain tumors in the mouse
$612,055Andrea Ventura · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Modeling BRAF-fusion driven pediatric brain tumors in the mouse
$612,055Andrea Ventura · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Near infrared intraoperative molecular imaging of lung adenocarcinoma
$612,052Sunil Singhal · University Of Pennsylvania · R01 · FY2019 · CA
FFPE Validation of a Survival Gene Signature in HPV-Negative Oral Cavity Cancer
$612,024Chu Chen · Fred Hutchinson Cancer Research Center · R01 · FY2017 · CA
Dual targeting of PI3K and NOS pathways in Metaplastic BreastCancer (MBC)
$611,983Jenny C-N Chang · Methodist Hospital Research Institute · R01 · FY2024 · CA
Construction of A Lung Cancer Preclinical Model Cross-comparison Platform
$611,831Ling Cai · Ut Southwestern Medical Center · R01 · FY2025 · CA
Integrating Multiple Electronic Health Records Systems to Improve Lung Cancer Outcomes
$611,784Summer S Han · Stanford University · R01 · FY2024 · CA
Building upon a tradition of excellence. The NCTN at Indiana University
$611,729Kathy D Miller · Indiana University Indianapolis · U10 · FY2016 · CA
Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens
$611,615William C Hahn · Dana-Farber Cancer Inst · U01 · FY2020 · CA
Appraisal and Diagnostic Delay in Colon Cancer
$611,611Maria D. Thomson · Virginia Commonwealth University · R01 · FY2012 · CA
Bioinformatic-Chemical Approach to Credential Molecular Targets to Combat Rapid Chemo-Radiation Resistance in SCLC
$611,606Luigi Marchionni · Johns Hopkins University · U01 · FY2018 · CA
Bioinformatic-Chemical Approach to Credential Molecular Targets to Combat Rapid Chemo-Radiation Resistance in SCLC
$611,606Christine L. Hann · Johns Hopkins University · U01 · FY2020 · CA
Improving smoking abstinence outcomes in the African American community through extended treatment
$611,590Lisa Sanderson Cox · University Of Kansas Medical Center · R01 · FY2024 · CA
Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
$611,560Washington University · N01 · FY2009 · CA
Gain-framed Messages and NRT Sampling to Promote Smoking Cessation in Lung Cancer Screening Programs
$611,518Benjamin Andrew Toll · Medical University Of South Carolina · R01 · FY2016 · CA
Evaluating Lung Cancer Screening Patterns and Outcomes through a North Carolina Registry
$611,504Louise Henderson · Univ Of North Carolina Chapel Hill · R01 · FY2020 · CA
MUC1-C Oncoprotein Evades Immune Destruction in Non-small Cell Lung Cancer
$611,442Donald W. Kufe · Dana-Farber Cancer Inst · R01 · FY2019 · CA
Highly multiplexed and mutation-sensitive quantitative PCR for cancer diagnostics
$611,416David Yu Zhang · Rice University · R01 · FY2016 · CA